These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 3510122

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lactate transport in L6 skeletal muscle cells and vesicles: allosteric or multisite mechanism and functional membrane marker of differentiation.
    Beaudry M, Mouaffak N, el Abida K, Rieu M, Mengual R.
    Acta Physiol Scand; 1998 Jan; 162(1):33-46. PubMed ID: 9492900
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Reversal by insulin of concanavalin A inhibition of myotube formation and evidence for common binding sites.
    Sandra A, Leon MA, Przybylski RJ.
    Endocrinology; 1979 Aug; 105(2):391-401. PubMed ID: 572292
    [Abstract] [Full Text] [Related]

  • 28. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells.
    Chalfant CE, Ohno S, Konno Y, Fisher AA, Bisnauth LD, Watson JE, Cooper DR.
    Mol Endocrinol; 1996 Oct; 10(10):1273-81. PubMed ID: 9121494
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential effects of fibroblast growth factor on insulin receptor and muscle specific protein gene expression in BC3H-1 myocytes.
    Brunetti A, Goldfine ID.
    Mol Endocrinol; 1990 Jun; 4(6):880-5. PubMed ID: 2172794
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation.
    Quinn LS, Roh JS.
    Exp Cell Res; 1993 Oct; 208(2):504-8. PubMed ID: 8375479
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes.
    Lamphere L, Lienhard GE.
    Endocrinology; 1992 Nov; 131(5):2196-202. PubMed ID: 1385098
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR, Ewton DZ, Coolican SA.
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [Abstract] [Full Text] [Related]

  • 35. Insulin binding to differentiating muscle cell line L6.
    Watanabe N, Kobayashi M, Iwasaki M, Ishibashi O, Takata Y, Shigeta Y.
    Diabetes Res Clin Pract; 1986 Oct; 2(5):283-9. PubMed ID: 3536369
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression and turnover of acylphosphatase (muscular isoenzyme) in L6 myoblasts during myogenesis.
    Berti A, Degl'Innocenti D, Stefani M, Ramponi G.
    Arch Biochem Biophys; 1992 Apr; 294(1):261-4. PubMed ID: 1312807
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hormonal stimulation of myoblast differentiation in the absence of DNA synthesis.
    Turo KA, Florini JR.
    Am J Physiol; 1982 Nov; 243(5):C278-84. PubMed ID: 6753603
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.